Fighting Virus Pandemics: The Now and The Future - Expert’s Perception of Challenges & Opportunities

APR 1 2020

 
 

Moderator:

Dr. Shawn Shi, Venture Partner at MSQ

Invited guests:

About Phagelux:

Phagelux utilizes phages, lysins and other biologics and related delivery technologies to create novel antibacterial products and solutions. Phagelux particularly targets anti-microbial resistant pathogens. It has R&D centers in Montreal, Canada and Wuhan, China. The former is focused on bacteriophage products while the latter develops lysin products.

For more information, please visit here.